Eczema drug interaction study completed: how rocatinlimab affects other medications
NCT ID NCT05891119
First seen Jan 11, 2026 · Last updated May 25, 2026 · Updated 26 times
Summary
This early-phase study looked at how rocatinlimab, a potential new treatment for moderate to severe eczema (atopic dermatitis), interacts with other common drugs. 21 adults with eczema took part. The goal was to measure drug levels in the blood and check for side effects, helping doctors understand if dose adjustments are needed when rocatinlimab is used with other medications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Accel Research Sites (ACR)
DeLand, Florida, 32720-3134, United States
-
Axis Clinicals, LCC
Dilworth, Minnesota, 56529, United States
-
DermDox Dermatology Centers, PC - Camp Hill
Camp Hill, Pennsylvania, 17011, United States
-
DermDox Dermatology Centers, PC - Sugarloaf
Nashville, Tennessee, 37203-1632, United States
-
Direct Helpers Research Center (DHRC)
Hialeah, Florida, 33012-3618, United States
-
Velocity Clinical Research -Spartanburg
Spartanburg, South Carolina, 29303-4225, United States
-
Velocity Clinical Research, North Hollywood
North Hollywood, California, 91606-1570, United States
Conditions
Explore the condition pages connected to this study.